|
Real-time Estimate
Cboe BZX
12:17:13 02/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 20.29 USD | -3.43% |
|
-8.71% | -34.03% |
| 14/08 | Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating | MT |
| 13/08 | Pelthos Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 8.04Cr 7.14Cr 6.68Cr 6.09Cr 11Cr 774.44Cr 12Cr 81Cr 31Cr 394.41Cr 30Cr 30Cr 1.27TCr | P/E 2026 * |
-1.23x | P/E 2027 * | -7.47x |
|---|---|---|---|---|---|
| Enterprise Value | 8.04Cr 7.14Cr 6.68Cr 6.09Cr 11Cr 774.44Cr 12Cr 81Cr 31Cr 394.41Cr 30Cr 30Cr 1.27TCr | EV / Sales 2026 * |
1.26x | EV / Sales 2027 * | 0.72x |
| Free-Float |
49.9% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PTHS | Delayed | |
CBOE
| PTHS | Real-time |
Last Transcript: Pelthos Therapeutics Inc.
| 1 day | -3.43% | ||
| 1 week | -8.71% | ||
| Current month | -2.67% | ||
| 1 month | -17.61% | ||
| 3 months | -26.96% | ||
| 6 months | -3.99% | ||
| Current year | -34.03% |
| 1 week | 20.23 |  | 22.92 |
| 1 month | 18.2 | | 26.1 |
| Current year | 18.19 | | 30.99 |
| 1 year | 18.19 | | 37.5 |
| 3 years | 4.5 | | 60 |
| 5 years | 4.5 | | 60 |
| 10 years | 4.5 | | 60 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/07/26 | Sell | Director | -558 | 0.0161% | ||
| 02/07/26 | Sell | Director | -786 | 0.0226% | ||
| 02/07/26 | Sell | Chairman | -797 | 0.0229% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.43% | -8.71% | -24.26% | - | 8.04Cr | |
| -0.72% | -2.83% | +39.13% | +113.35% | 1,03100Cr | |
| -1.95% | -4.16% | +39.44% | +67.21% | 64TCr | |
| -0.45% | -1.55% | +6.80% | +76.06% | 46TCr | |
| -1.18% | -2.77% | +59.64% | +40.30% | 36TCr | |
| -0.03% | -3.96% | +23.63% | +40.70% | 33TCr | |
| -1.58% | -0.76% | +13.50% | +26.44% | 27TCr | |
| -2.02% | -2.97% | -3.25% | +9.88% | 25TCr | |
| -2.33% | +1.55% | +38.14% | +54.83% | 23TCr | |
| -0.72% | -1.12% | +33.17% | +99.76% | 18TCr | |
| Average | -1.48% | -1.39% | +22.59% | +58.73% | 37.64TCr | |
| Weighted average by Cap. | -1.17% | -0.35% | +30.72% | +70.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.37Cr 5.66Cr 5.29Cr 4.83Cr 9.08Cr 613.75Cr 9.21Cr 64Cr 25Cr 312.57Cr 24Cr 23Cr 1TCr | 11Cr 9.97Cr 9.32Cr 8.49Cr 16Cr 1.08TCr 16Cr 112.76Cr 44Cr 550.25Cr 42Cr 41Cr 1.77TCr |
| Net income | -6.21Cr -5.51Cr -5.16Cr -4.7Cr -8.85Cr -597.72Cr -8.97Cr -62Cr -24Cr -304.41Cr -23Cr -23Cr -977.74Cr | -2.5Cr -2.22Cr -2.07Cr -1.89Cr -3.56Cr -240.28Cr -3.61Cr -25Cr -9.71Cr -122.37Cr -9.37Cr -9.17Cr -393.04Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $20.45 | -2.67% | 27,094 |
| 30/26/30 | $21.01 | +0.43% | 5,453 |
| 29/26/29 | $20.92 | -1.55% | 9,445 |
| 28/26/28 | $21.25 | -4.24% | 12,007 |
| 25/26/25 | $22.19 | -0.94% | 14,850 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTHS Stock
Select your edition
All financial news and data tailored to specific country editions
